Mydecine Innovations Group Inc. (NEO:MYCO) (OTCMKTS:MYCOF) (FRA:0NFA) CEO Josh Bartch tells Proactive its R&D team has made groundbreaking advances.
Mydecine to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17th
06/03/2021 | 07:30am EDT
Send by mail :
Message :
DENVER, June 03, 2021 (GLOBE NEWSWIRE)
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, today announced that Josh Bartch, CEO of Mydecine, will participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference to be hosted virtually on Thursday, June 17, 2021.
Mr. Bartch’s corporate presentation will be available on-demand starting at 7:00 a.m. ET. To attend, register
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types. The company said research shows that the xB3 platform can cross intact BBB and enter intracellular organelles within neurons, glia and microglia in the brain. It said the data from a study published on June 2 in the Frontiers in Neuroscience provide evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB.
NA Proactive news snapshot: Fortitude Gold, BlueRush, Sassy Resources, Organic Garage, Alpine 4 Holdings, Lucky Minerals UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Fortitude Gold Corp (OTCQB:FTCO) announced the timing of its first quarter 2021 earnings conference call scheduled for Wednesday, May 12, 2021. CEO Jason Reid will host the conference call at 11:00 AM ET. Topics of discussion will include first quarter results and an update on current operations. The conference call will be recorded and posted to the company s website. To join the conference via webcast, please click on the following link: https://www.webcaster4.com/Webcast/Page/2640/41269. To join the call via telephone please use one of the following dial-in details: Toll Free: 877-407-8031 or International: 201-689-8031.